The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Neurodegeneration in multiple sclerosis: The role of oxidative stress and excitotoxicity
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A., & Freeman, B. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1620 · Cited by 7,029
Nitric Oxide and Peroxynitrite in Health and Disease
Pacher, P., Beckman, J. S., & Liaudet, L. (2007) · Physiological Reviews · doi:10.1152/physrev.00029.2006 · Cited by 6,390
Ames, B. N., Cathcart, R., Schwiers, E., & Hochstein, P. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.11.6858 · Cited by 2,909
Peroxynitrite: biochemistry, pathophysiology and development of therapeutics
Szabó, C., Ischiropoulos, H., & Radi, R. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2222 · Cited by 2,134
Kainic acid as a tool in neurobiology
McGeer, E. G., Olney, J. W., & McGeer, P. L. (1978) · Raven Press eBooks · Cited by 1,308
Regulatory Mechanisms Controlling Gene Expression Mediated by the Antioxidant Response Element
Nguyen, T., Sherratt, P. J., & Pickett, C. B. (2003) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.100901.140229 · Cited by 1,236
Oxidative Stress: Introductory Remarks
SIES, H. (1985) · Oxidative Stress · doi:10.1016/b978-0-12-642760-8.50005-3 · Cited by 985
Oxidative Stress and Neurotoxicity
Sayre, L. M., Perry, G., & Smith, M. A. (2008) · Chemical Research in Toxicology · doi:10.1021/tx700210j · Cited by 867
Glutamate excitotoxicity in a model of multiple sclerosis
Pitt, D., Werner, P., & Raine, C. S. (2000) · Nature Medicine · doi:10.1038/71555 · Cited by 744
Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial
Gordon, P. H., Moore, D. H., Miller, R. G., Florence, J. M., Verheijde, J. L., Doorish, C., Hilton, J. F., Spitalny, G. M., MacArthur, R. B., Mitsumoto, H., et al. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70270-3 · Cited by 649
Hooper, D. C., Spitsin, S., Kean, R. B., Champion, J. M., Dickson, G. M., Chaudhry, I., & Koprowski, H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.2.675 · Cited by 569
Reaction of superoxide with nitric oxide to form peroxonitrite in alkaline aqueous solution
Blough, N. V., & Zafiriou, O. C. (1985) · Inorganic Chemistry · doi:10.1021/ic00216a003 · Cited by 523
Coles, A. J., Cox, A., Page, E., Jones, J., Trip, S. A., Deans, J., Seaman, S., Miller, D. H., Hale, G., Waldmann, H., et al. (2006) · Journal of Neurology · doi:10.1007/s00415-005-0934-5 · Cited by 506
Werner, P., Pitt, D., & Raine, C. S. (2001) · Annals of Neurology · doi:10.1002/ana.1077 · Cited by 486
Autoimmune encephalomyelitis ameliorated by AMPA antagonists
Smith, T., Groom, A., Zhu, B., & Turski, L. (2000) · Nature Medicine · doi:10.1038/71548 · Cited by 467
Chen, X.-L., Dodd, G., Thomas, S., Zhang, X., Wasserman, M. A., Rovin, B. H., & Kunsch, C. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00651.2005 · Cited by 418
Plasma Urate and Risk of Parkinson's Disease
Weisskopf, M., O'Reilly, E., Chen, H., Schwarzschild, M., & Ascherio, A. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm127 · Cited by 390
NBQX Attenuates Excitotoxic Injury in Developing White Matter
Follett, P. L., Rosenberg, P. A., Volpe, J. J., & Jensen, F. E. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09235.2000 · Cited by 390
Hooper, D. C., Scott, G. S., Zborek, A., Mikheeva, T., Kean, R. B., Koprowski, H., & Spitsin, S. V. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.5.691 · Cited by 390
Neuroinflammation and regulation of glial glutamate uptake in neurological disorders
Tilleux, S., & Hermans, E. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21325 · Cited by 381
Altered Uric Acid Levels and Disease States
Kutzing, M. K., & Firestein, B. L. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.129031 · Cited by 374
Squadrito, G. L., Cueto, R., Splenser, A. E., Valavanidis, A., Zhang, H., Uppu, R. M., & Pryor, W. A. (2000) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2000.1721 · Cited by 364
Yu, Z. F., Bruce-Keller, A. J., Goodman, Y., & Mattson, M. P. (1998) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19980901)53:5<613::aid-jnr11>3.0.co;2-1 · Cited by 359
Lost in translation: Treatment trials in the SOD1 mouse and in human ALS
Benatar, M. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.12.015 · Cited by 350
The link between excitotoxic oligodendroglial death and demyelinating diseases
Matute, C., Alberdi, E., Domercq, M., Pérez-Cerdá, F., Pérez-Samartı́n, A., & Sánchez-Gómez, M. V. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01746-x · Cited by 348
Expression of Inducible Nitric Oxide Synthase and Nitrotyrosine in Multiple Sclerosis Lesions
Liu, J. S.-H., Zhao, M.-L., Brosnan, C. F., & Lee, S. C. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64677-9 · Cited by 311
Li, S., & Stys, P. K. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-03-01190.2000 · Cited by 307
Serum uric acid levels and the risk of Parkinson disease
de Lau, L. M. L., Koudstaal, P. J., Hofman, A., & Breteler, M. M. B. (2005) · Annals of Neurology · doi:10.1002/ana.20663 · Cited by 301
Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity?
Marik, C., Felts, P. A., Bauer, J., Lassmann, H., & Smith, K. J. (2007) · Brain · doi:10.1093/brain/awm236 · Cited by 292
Decreased plasma antioxidants in patients with Alzheimer's disease
Kim, T.-S., Pae, C.-U., Yoon, S.-J., Jang, W.-Y., Lee, N. J., Kim, J.-J., Lee, S.-J., Lee, C., Paik, I.-H., & Lee, C.-U. (2006) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1469 · Cited by 291
Gunasekar, P. G., Kanthasamy, A. G., Borowitz, J. L., & Isom, G. E. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65052016.x · Cited by 283
Glutamate uptake by oligodendrocytes: Implications for excitotoxicity in multiple sclerosis
Pitt, D., Nagelmeier, I. E., Wilson, H. C., & Raine, C. S. (2003) · Neurology · doi:10.1212/01.wnl.0000090564.88719.37 · Cited by 222
Schimrigk, S., Brune, N., Hellwig, K., Lukas, C., Bellenberg, B., Rieks, M., Hoffmann, V., Pöhlau, D., & Przuntek, H. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01292.x · Cited by 217
Peroxynitrite formation within the central nervous system in active multiple sclerosis
Cross, A. H., Manning, P. T., Keeling, R. M., Schmidt, R. E., & Misko, T. P. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00078-2 · Cited by 201
The Brain as a Target for Inflammatory Processes and Neuroprotective Strategies
SKAPER, S. D. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1403.002 · Cited by 192
Vercellino, M., Merola, A., Piacentino, C., Votta, B., Capello, E., Mancardi, G. L., Mutani, R., Giordana, M. T., & Cavalla, P. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31812571b0 · Cited by 190
Vargas, M. R., Pehar, M., Cassina, P., Beckman, J. S., & Barbeito, L. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03742.x · Cited by 180
Gray, E., Thomas, T. L., Betmouni, S., Scolding, N., & Love, S. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00110.x · Cited by 175
Sharp, C. D., Hines, I., Houghton, J., Warren, A., Jackson, T. H., Jawahar, A., Nanda, A., Elrod, J. W., Long, A., Chi, A., et al. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00520.2003 · Cited by 174
Schreibelt, G., van Horssen, J., van Rossum, S., Dijkstra, C. D., Drukarch, B., & de Vries, H. E. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.07.005 · Cited by 171
Gout and risk of Parkinson disease: A prospective study
Alonso, A., Rodríguez, L. A. G., Logroscino, G., & Hernán, M. A. (2007) · Neurology · doi:10.1212/01.wnl.0000279518.10072.df · Cited by 166
Glutamate Receptor Expression in Multiple Sclerosis Lesions
Newcombe, J., Uddin, A., Dove, R., Patel, B., Turski, L., Nishizawa, Y., & Smith, T. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00101.x · Cited by 164
Hill, K. E., Zollinger, L. V., Watt, H. E., Carlson, N. G., & Rose, J. W. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.02.005 · Cited by 158
Kean, R. B., Spitsin, S. V., Mikheeva, T., Scott, G. S., & Hooper, D. C. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.11.6511 · Cited by 157
Leist, M., Fava, E., Montecucco, C., & Nicotera, P. (1997) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1997.tb01503.x · Cited by 156
Extensive peroxynitrite activity during progressive stages of central nervous system inflammation
van der Veen, R. C., Hinton, D. R., Incardona, F., & Hofman, F. M. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00013-1 · Cited by 155
Low plasma uric acid level in Parkinson's disease
Annanmäki, T., Muuronen, A., & Murros, K. E. (2007) · Movement Disorders · doi:10.1002/mds.21502 · Cited by 153
Free radical scavenging, DNA protection, and inhibition of lipid peroxidation mediated by uric acid.
Stinefelt, B. M., Leonard, S. S., Blemings, K. P., Shi, X., & KLANDORF, H. (2005) · PubMed · Cited by 150
Oleszak, E. L., Zaczyńska, E., Bhattacharjee, M. B., Butunoi, C., Legido, A., & Katsetos, C. D. (1998) · Clinical and Diagnostic Laboratory Immunology · doi:10.1128/cdli.5.4.438-445.1998 · Cited by 138
Tončev, G., Miličić, B., Tončev, S., & Samardžić, G. (2002) · European Journal of Neurology · doi:10.1046/j.1468-1331.2002.00384.x · Cited by 137
CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis
Rejdak, K., Eikelenboom, M. J., Petzold, A., Thompson, E. J., Stelmasiak, Z., Lazeron, R. H. C., Barkhof, F., Polman, C. H., Uitdehaag, B. M. J., & Giovannoni, G. (2004) · Neurology · doi:10.1212/01.wnl.0000142043.32578.5d · Cited by 129
Uric acid protects against secondary damage after spinal cord injury
Scott, G. S., Cuzzocrea, S., Genovese, T., Koprowski, H., & Hooper, D. C. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500307102 · Cited by 128
Comparison of uric acid and ascorbic acid in protection against EAE
Spitsin, S. V., Scott, G. S., Mikheeva, T., Zborek, A., Kean, R. B., Brimer, C. M., Koprowski, H., & Hooper, D. C. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01048-1 · Cited by 125
Multiple sclerosis and Alzheimer's disease
Dal Bianco, A., Bradl, M., Frischer, J., Kutzelnigg, A., Jellinger, K., & Lassmann, H. (2008) · Annals of Neurology · doi:10.1002/ana.21240 · Cited by 123
Detoxication enzyme inducers modify cytokine production in rat mixed glial cells
Wierinckx, A., Brevé, J. J. P., Mercier, D., Schultzberg, M., Drukarch, B., & van Dam, A. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.05.013 · Cited by 122
Uric acid levels in sera from patients with multiple sclerosis
Drulovic, J. S., Dujmović, I., Stojsavljević, N., Mesaroš, Š., Andjelković, S., Miljković, D. M., Perić, V., Dragutinović, G., Marinković, J., Lević, Z., et al. (2001) · Journal of Neurology · doi:10.1007/s004150170246 · Cited by 113
Wallström, E., Diener, P., Ljungdahl, Å., Khademi, M., Nilsson, C.-G., & Olsson, T. P. (1996) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(95)00339-4 · Cited by 111
Heme oxygenase-1 plays an important protective role in experimental autoimmune encephalomyelitis
Liu, Y., Zhu, B., Luo, L., Li, P., Paty, D. W., & Cynader, M. S. (2001) · Neuroreport · doi:10.1097/00001756-200107030-00016 · Cited by 109
Astroglia‐mediated effects of uric acid to protect spinal cord neurons from glutamate toxicity
Du, Y., Chen, C., Tseng, C., Eisenberg, Y., & Firestein, B. L. (2007) · Glia · doi:10.1002/glia.20472 · Cited by 109
Black, J. A., Liu, S., Carrithers, M. D., Carrithers, L. M., & Waxman, S. G. (2007) · Annals of Neurology · doi:10.1002/ana.21172 · Cited by 108
Spitsin, S. V., Hooper, D. C., Leist, T. P., Streletz, L. J., Mikheeva, T., & Koprowski, H. (2001) · Multiple Sclerosis Journal · doi:10.1177/135245850100700507 · Cited by 105
Review: Oxidative stress and excitotoxicity: a therapeutic issue in multiple sclerosis?
Gonsette, R. E. (2007) · Multiple Sclerosis Journal · doi:10.1177/1352458507080111 · Cited by 103
Self-citationMultifaceted aspects of inflammation in multiple sclerosis: The role of microglia
Muzio, L., Martino, G., & Furlan, R. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.09.016 · Cited by 101
Activation of Kainate Receptors Sensitizes Oligodendrocytes to Complement Attack
Alberdi, E. M., Sánchez‐Gómez, M. V., Torre, I., Domercq, M., Pérez‐Samartín, A., Pérez‐Cerdá, F., & Matute, C. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3780-05.2006 · Cited by 96
Zhang, Y., Xu, Y., Liu, Y., Yin, J., Li, H., Wang, Q., & Wang, J. (2006) · The FASEB Journal · doi:10.1096/fj.05-5223com · Cited by 91
Werner, P., Pitt, D., & Raine, C. S. (2000) · Springer eBooks · doi:10.1007/978-3-7091-6301-6_27 · Cited by 87
Glutamate inhibition in MS: The neuroprotective properties of riluzole
Killestein, J., Kalkers, N. F., & Polman, C. H. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.03.011 · Cited by 79
Jack, C. S., Antel, J. P., Brück, W., & Kuhlmann, T. (2007) · Glia · doi:10.1002/glia.20514 · Cited by 73
Rejdak, K., Petzold, A., Stelmasiak, Z., & Giovannoni, G. (2007) · Multiple Sclerosis Journal · doi:10.1177/1352458507082061 · Cited by 71
Contrasting roles for nitric oxide and peroxynitrite in the peroxidation of myelin lipids
van der Veen, R. C., & Roberts, L. J. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00239-2 · Cited by 70
Serum uric acid levels of patients with multiple sclerosis and other neurological diseases
Peng, F., Zhang, B., Zhong, X., Li, J., Xu, G., Hu, X., Qiu, W., & Pei, Z. (2007) · Multiple Sclerosis Journal · doi:10.1177/1352458507082143 · Cited by 67
Scott, G. S., Bowman, S., Smith, T., Flower, R. J., & Bolton, C. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.09.021 · Cited by 66
In vivo damage of CNS myelin and axons induced by peroxynitrite
Touil, T., Deloire-Grassin, M., Vital, C., Petry, K. G., & Brochet, B. (2001) · Neuroreport · doi:10.1097/00001756-200111160-00052 · Cited by 62
Glantz, L., Avramovich, A., Trembovler, V., Gurwitz, V., Kohen, R., Eidelman, L. A., & Shohami, E. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2004.11.012 · Cited by 62
Plumb, R. C., Tantayanon, R., Libby, M., & Xu, W. W. (1989) · Nature · doi:10.1038/338633a0 · Cited by 60
Orrell, R. W. (2006) · PubMed · Cited by 48
Secondary degeneration reduced by inosine after spinal cord injury in rats
Liu, F., You, S.-W., Yao, L.-P., Liu, H.-L., Jiao, X.-Y., Shi, M., Zhao, Q.-B., & Ju, G. (2005) · Spinal Cord · doi:10.1038/sj.sc.3101878 · Cited by 48
Uric acid levels in patients with multiple sclerosis: analysis in mono- and dizygotic twins
Spitsin, S. V., Hooper, D. C., Mikheeva, T., et al. (2001) · Multiple Sclerosis Journal · doi:10.1177/135245850100700305 · Cited by 47
A catalyst of peroxynitrite decomposition inhibits murine experimental autoimmune encephalomyelitis
Cross, A. H., San, M., Stern, M. K., Keeling, R. M., Salvemini, D., & Misko, T. P. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00242-3 · Cited by 41
Serum uric acid levels in optic neuritis
Knapp, C. M., Constantinescu, C. S., Tan, J. H., McLean, R. J., Cherryman, G. R., & Gottlob, I. (2004) · Multiple Sclerosis Journal · doi:10.1191/1352458504ms1042oa · Cited by 39
Peroxiredoxin V in multiple sclerosis lesions: predominant expression by astrocytes
Holley, J. E., Newcombe, J., Winyard, P. G., & Gutowski, N. J. (2007) · Multiple Sclerosis Journal · doi:10.1177/1352458507078064 · Cited by 38
Burdo, J. R., Schubert, D. A., & Maher, P. A. (2007) · Brain Research · doi:10.1016/j.brainres.2007.10.077 · Cited by 37
Adenoviral Gene Therapy With Catalase Suppresses Experimental Optic Neuritis
Guy, J. (1999) · Archives of Ophthalmology · doi:10.1001/archopht.117.11.1533 · Cited by 29
Reactivity of Peroxynitrite: Implications for Hanford Waste Management and Remediation
Brookhaven National Lab., U., Lymar, S. V., USDOE Office of Environmental Management (EM) (US), et al. (2000) · doi:10.2172/828435 · Cited by 3
Cited by
Free Radicals: Properties, Sources, Targets, and Their Implication in Various Diseases
Phaniendra, A., Jestadi, D. B., & Periyasamy, L. (2015) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-014-0446-0 · Cited by 2,886
Lewerenz, J., Hewett, S. J., Huang, Y., Lambros, M., Gout, P. W., Kalivas, P. W., Massie, A., Smolders, I., Methner, A., Pergande, M., et al. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4391 · Cited by 978
The role of methionine on metabolism, oxidative stress, and diseases
Martínez, Y., Li, X., Liu, G., Bin, P., Yan, W., Más, D., Valdivié, M., Hu, C.-A. A., Ren, W., & Yin, Y. (2017) · Amino Acids · doi:10.1007/s00726-017-2494-2 · Cited by 583
Nutraceutical Antioxidants as Novel Neuroprotective Agents
Kelsey, N. A., Wilkins, H. M., & Linseman, D. A. (2010) · Molecules · doi:10.3390/molecules15117792 · Cited by 480
ROS and Brain Diseases: The Good, the Bad, and the Ugly
Popa-Wagner, A., Mitran, S., Sivanesan, S., Chang, E., & Buga, A.-M. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/963520 · Cited by 427
Metadata
- Authors
- Gonsette, R. E.
- Venue
- Journal of the Neurological Sciences
- Publisher
- Elsevier BV
- Published
- 2008-11
- Volume
- 274
- Issue
- 1-2
- Pages
- 48-53
- ISSN
- 0022-510X (ISSN-L)
- OpenAlex
- W2017360920
- Cited by
- 267
- References
- 84
- FWCI
- 9.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.